Psychiatrists' decision making between branded and generic drugs

European Neuropsychopharmacology

Volumn 23, Issue 7, 2013, Pages 686-690

  Hamann, Johannes ^a   Mendel, Rosmarie ^a   Kissling, Werner ^a   Leucht, Stefan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Decision making; Generic substitution; Prescriptions

Indexed keywords

ANTIDEPRESSANT AGENT; GENERIC DRUG; NEUROLEPTIC AGENT; PLACEBO;

ADULT; ARTICLE; DECISION MAKING; DEPRESSION; DRUG CHOICE; FEMALE; HEALTH SURVEY; HUMAN; MALE; OUTPATIENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PSYCHIATRIST; REGRESSION ANALYSIS; SCHIZOPHRENIA;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; PSYCHIATRY;

EID: 84878861353     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.08.007     Document Type: Article

References (11)

1. Blier P. Generic medications: another variable in the treatment of illnesses. J. Psychopharmacol. 2007, 21:459-460.
2. Dalbert C. Die Ungewissheitstoleranzskala: Skaleneigenschaften und Validierungsbefunde 1999, Martin-Luther-Universität Halle-Wittenberg, Germany.
3. Hamann J., Adjan S., Leucht S., Kissling W. Psychiatric decision making in the adoption of a new antipsychotic in Germany. Psych. Serv. 2006, 57:700-703.
4. Kersnik J., Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J. Clin. Pharm. Ther. 2006, 31:577-583.
5. Kluznik J.C., Walbek N.H., Farnsworth M.G., Melstrom K. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. J. Clin. Psychiatry 2001, 62(Suppl. 5):14-17. (discussion 23-14).
6. Kray L., Gonzalez R. Differential weighting in choice versus advice: I'll do this, you do that. J. Behav. Decis. Making 1999, 12:207-217.
7. Mendel R., Hamann J., Traut-Mattausch E., Buhner M., Kissling W., Frey D. 'What would you do if you were me, doctor?': randomised trial of psychiatrists' personal v. professional perspectives on treatment recommendations. Br. J. Psychiatry 2010, 197:441-447.
8. Nuss P., Taylor D., De Hert M., Hummer M. The generic alternative in schizophrenia: opportunity or threat?. CNS Drugs 2004, 18:769-775.
9. Roman B. Patients' attitudes towards generic substitution of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical pharmacy setting. CNS Drugs 2009, 23:693-701.
10. Simmenroth-Nayda A., Hummers-Pradier E., Ledig T., Jansen R., Niebling W., Bjerre L.M., Kochen M.M., Himmel W. Prescription of generic drugs in general practice. Results of a survey of general practitioners. Med. Klin. 2006, 101:705-710.
11. Van Ameringen M., Mancini C., Patterson B., Bennett M. Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series. J. Psychopharmacol. 2007, 21:472-476.